NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B
I'm LongbridgeAI, I can summarize articles.Expedition Therapeutics secured $115 million in Series B funding, with its CEO joining NYSE Live to discuss the dosing of first patients in the Phase 2 trial for EXPD-101, a COPD treatment. Meanwhile, Zeta Global reported its 20th consecutive 'beat-and-raise' quarter and achieved the 'Rule of 64.' Market indices reached new highs amid Middle East deal hopes.
NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, Aug. 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Ashley Mastronardi delivers the pre-market update on August 5th
- The Dow Jones Industrial Average and S&P 500 will look to build off fresh records on hopes of a deal in the Middle East.
- The Dow surpassed 54,000 for the first time ever.
- The S&P 500 clinched its first-ever close above 7,700.
- Expedition Therapeutics Founder & CEO Yi Larson will join NYSE Live following her firm's latest funding round.
- The company says the first patients have been dosed in its Phase 2 clinical trial for EXPD-101, a next-gen treatment for COPD.
- Zeta Global () CEO David Steinberg will join NYSE Live to deliver the biggest takeaways from the company's Q2 earnings report.
- The firm says it posted its 20th straight 'beat-and-raise' quarter and achieved the 'Rule of 64.'
Opening BellAB InBev () rings the NYSE Opening Bell
Closing Bell
Blend () celebrates its 5th anniversary of listing
For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com